Organic compounds

Details for Australian Patent Application No. 2004228929

Owner Details removed by request.

Inventors Details removed by request.

Agent Details removed by request.

Pub. Number AU-B-2004228929

PCT Pub. Number WO2004/089341

Priority 60/461,215 08.04.03 US

Filing date 6 April 2004

Wipo publication date 21 October 2004

Acceptance publication date 7 February 2008

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/36 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 9/62 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

6 October 2005 PCT application entered the National Phase

7 February 2008 Application Accepted

5 June 2008 Standard Patent Sealed

18 August 2011 Alteration of Name

18 August 2011 Extension of Term of Standard Patents

25 August 2011 Extension of Term of Standard Patents

2 February 2012 Extension granted

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004228932-Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for "CEST" applications

2004228927-Transdermal administration of (R)-3,3-diphenylpropylamine monoesters